Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched.
Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release.
“The dramatically increased use of remote patient telemetry devices coupled with the rapidly accelerating development of AI and machine learning algorithms has the potential to revolutionize diagnostic medicine,” Mayo Clinic Platform president Dr. John Halamka said in the release. “With RDMP, clinicians will have access to best-in-class algorithms and care protocols and will be able to serve more patients effectively in remote care settings. The platform will also enable patients to take more control of their health and make better decisions based on insights delivered directly to them.”
With RDMP, Mayo Clinic has now launched two companies with partners to support the platform.
The clinic and nference formed a startup called Anumana to create and bring to market digital sensor diagnostics through a combination of AI technology developed by nference and Mayo’s repository of medical data.
Among the offerings will be neural network algorithms based on heart health data in Mayo’s clinical data analytics platform, including raw electrocardiogram (ECG) signals, to unlock hidden biomedical knowledge and allow for early detection and accelerated treatment with heart disease.
Anumana completed a $25.7 million Series A financing round to help fund the development and commercialization of the ECG technology and multimodal algorithms for clinical care.
“ECGs have been read and notated manually by physicians for more than a century,” nference co-founder & CEO Murali Aravamudan, now CEO of Anumana, said. “Our augmented intelligence technology, in the hands of scientific and clinical experts, will enable a comprehensive translation of the language of the heart. We think of it as the Rosetta Stone for cardiac medicine.”
Commure joined Mayo to launch Lucem Health, which sets out to provide the overall platform for connecting remote patient telemetry devices with AI-enabled algorithms, including those developed by Anumana and Mayo Clinic.
Lucem’s platform will collect, orchestrate and curate data from virtually any advice while hosting and supporting AI/machine learning runtime algorithms and delivering application development frameworks and services.
The company picked up $6 million in Series A financing to help build out its platform for serving AI-generated diagnostic insights to the point of care.
“Lucem Health exists to help diagnostic medicine innovations see the light of day,” says Sean Cassidy, founding CEO of Lucem Health. “We are excited to work with partners like Mayo Clinic and Anumana that are reimagining how we detect and treat diseases.”
